Woman and Man | 18 years and more
- | Country :
- France
- | organs :
- Myélomes
- | Specialty :
- Thérapies Ciblées
- Chimiothérapie
Extract
A phase 1b, multicenter, open-label, dose-escalation study of HuLuc63 (humanized anti-cs1 monoclonal IgG1 antibody) in combination with lenalidomide and dexamethasone in subjects with relapsed multiple myeloma.
Scientific Abstract
en cours d'intégration;